The method is aimed at colorectal and lung cancers, which are difficult to diagnose in their earliest stages.
Using tiny “nanopore” scanners that can detect individual DNA molecules, Professor Amit Meller and colleagues are on the hunt for biological markers in cancer cells that may help clinicians diagnose colorectal and lung cancers at their earliest stages.
Prof. Meller, of the Faculty of Biomedical Engineering at the Technion-Israel Institute of Technology, leads a research group that is a partner in BeyondSeq, an international research consortium looking for new methods of decoding genetic and epigenetic information from medical samples. BeyondSeq, supported by a €6 million grant from Horizon 2020, the European Union’s framework program, was one of only eight consortia chosen out of 450 submitted proposals.
“We are the only lab in the consortium working on early diagnosis of cancer biomarkers, which…will allow doctors to combat the cancers much more effectively and save human lives,” Meller explained. “Currently there are no good ways to diagnose colorectal cancer and lung cancer at early stages. Usually these cancers are diagnosed at later stage (stage 2 or above) in which the patients may already have multiple secondary tumors, hence highly complicating treatment.”
The nanopore technology developed by Meller and colleagues consists of tiny holes—about 100,000 times smaller than the thickness of a sheet of paper—drilled in ultra-thin silicon membranes. The researchers pass a current of electrically charged salt ions through the nanopore that attracts molecules such as DNA, which have their own natural electrical change, toward the pores. The DNA molecules are threaded through the pore and as they slide from one side of the membrane to the other, the pore acts as a scanner. Both optical and electrical signals given off as the molecule passes through the pore are detected providing information on the DNA properties, such as its length and sequence variations.
Meller said his team will be using the nanopores to looking at slight variations in the DNA nucleotides or “letters” that spell out the KRAS gene, which has already been identified as an important biomarker in colorectal and lung cancers. “We can encode the nucleotides variations in the KRAS gene with sets of color-emitting dyes and read the information with our nanopore sensor. We hope that our nanopore technology can be adapted for early detection, where the sensing of these biomarkers is currently extremely challenging and not accessible by conventional methods,” he said.
Nanopores could prove especially useful for early detection because they can scan very small amounts of molecules, uncovering the few cancerous cells or molecular markers of cancer in a large sample of healthy blood or tissue, he added.
The team is also developing a nanopore-based method to detect epigenetic modifications at the single-molecule level. Epigenetic modifications are chemical changes made to a DNA molecule. These chemical changes don’t alter the sequence of DNA letters that spells out a gene, but they can affect how the protein encoded by that gene is expressed inside a cell. (Some people have likened this difference to the markings on a musical score: think of the genetic sequence as the musical notes, while the epigenetic modifications are the instructions that tell a musician whether to play the note softly or loudly, for instance.)
Nanopores offer one way to see whether a piece of DNA has some of these epigenetic instructions attached to it, which could help scientists determine whether any of these instructions correlate to how a disease like cancer develops.
Meller and his colleagues have been developing the possibilities of nanopores for more than 15 years. In a paper published in Scientific Reports earlier this year, they demonstrated that the pores could detect the presence of a single transcription factor, a protein that activates the production of messenger RNA from the DNA. The pore’s scanning capabilities were even powerful enough to distinguish between two separate ways that the transcription factor could bind itself to the DNA, each with its own transcriptional effects.
The Latest on: Nanopore Scanners
via Google News
The Latest on: Nanopore Scanners
- Your sense of smell may be the key to a balanced dieton August 28, 2021 at 10:02 am
Participants completed the task twice inside an MRI scanner: First, when they were hungry, then, after they'd eaten a meal that matched one of the two odors. "In parallel with the first part of ...
- Cancer Research & Oncology 2017on August 25, 2021 at 5:00 pm
The 5th Annual LabRoots Cancer Research & Oncology Virtual Conference is now On-Demand! LabRoots invites research professionals, scientists, and clinicians to this premier online conference, making it ...
- Genetics and Genomicson August 24, 2021 at 5:01 pm
The LabRoots 4 th Annual Genetics and Genomics free virtual conference was a wonderful event for research scientists, post docs, principal investigators, lab directors and other genetics professionals ...
- UNM technology accelerates genomic sequencingon August 19, 2021 at 5:00 pm
Brueck’s group has created a new, “optical nanopore sequencing” technique ... work on building additional capacity into optical scanners to accurately read the individual strands of DNA.
- Metagenomic Sequencing Market to Climb Sharply with Fantastic CAGR by 2028, Key Players -Illumina, Inc. (US), Thermo Fisher Scientific, Inc (US)on August 19, 2021 at 8:00 am
openPR disclaims liability for any content contained in this release. Veterinary Ultrasound Scanner Market Survey Report Discloses ‘Strategy 2027’ … New York, United States: Our wizards in ...
- A novel virtual reality technology to make MRI a new experienceon August 11, 2021 at 6:58 am
To provide patients with an immersive VR environment, the researchers developed a special VR headset that can be safely used inside MRI scanner. The headset is designed to be light tight ...
- Single chip tests thousands of enzyme mutations at onceon July 22, 2021 at 5:00 pm
The chip then added a chemical that gives off light when it is processed by PafA. A scanner measured the amount of light given off by the chemical: mutations that made PafA less effective made the ...
- The fledgling industries emerging from our universitieson August 2, 2018 at 3:37 am
Oxford Nanopore alone accounts for 26.9% of it ... £20m and the product range included superconducting magnets for MRI scanners. The firm was floated on the London stock exchange in 1983.
- The pharmas making pills tailored to your geneson April 19, 2018 at 6:00 am
Low-cost portable DNA sequencers are also now being made and sold by Oxford Nanopore, a UK company in which IP Group has a 19.6% stake. Oxford's latest funding round has raised funds to build a ...
via Bing News